JP2019141061A5 - - Google Patents

Download PDF

Info

Publication number
JP2019141061A5
JP2019141061A5 JP2019067570A JP2019067570A JP2019141061A5 JP 2019141061 A5 JP2019141061 A5 JP 2019141061A5 JP 2019067570 A JP2019067570 A JP 2019067570A JP 2019067570 A JP2019067570 A JP 2019067570A JP 2019141061 A5 JP2019141061 A5 JP 2019141061A5
Authority
JP
Japan
Prior art keywords
plant
modified influenza
type
influenza
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019067570A
Other languages
English (en)
Japanese (ja)
Other versions
JP7065803B2 (ja
JP2019141061A (ja
Filing date
Publication date
Application filed filed Critical
Publication of JP2019141061A publication Critical patent/JP2019141061A/ja
Publication of JP2019141061A5 publication Critical patent/JP2019141061A5/ja
Application granted granted Critical
Publication of JP7065803B2 publication Critical patent/JP7065803B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019067570A 2013-03-28 2019-03-29 植物におけるインフルエンザウイルス様粒子の生成 Active JP7065803B2 (ja)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US201361806227P 2013-03-28 2013-03-28
US61/806,227 2013-03-28
US201461925852P 2014-01-10 2014-01-10
US61/925,852 2014-01-10
US201461971274P 2014-03-27 2014-03-27
US61/971,274 2014-03-27

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2016504431A Division JP2016516415A (ja) 2013-03-28 2014-03-28 植物におけるインフルエンザウイルス様粒子の生成

Publications (3)

Publication Number Publication Date
JP2019141061A JP2019141061A (ja) 2019-08-29
JP2019141061A5 true JP2019141061A5 (enExample) 2020-02-13
JP7065803B2 JP7065803B2 (ja) 2022-05-12

Family

ID=51622327

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016504431A Pending JP2016516415A (ja) 2013-03-28 2014-03-28 植物におけるインフルエンザウイルス様粒子の生成
JP2019067570A Active JP7065803B2 (ja) 2013-03-28 2019-03-29 植物におけるインフルエンザウイルス様粒子の生成

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2016504431A Pending JP2016516415A (ja) 2013-03-28 2014-03-28 植物におけるインフルエンザウイルス様粒子の生成

Country Status (14)

Country Link
US (2) US10358652B2 (enExample)
EP (2) EP2978848B1 (enExample)
JP (2) JP2016516415A (enExample)
KR (1) KR102199018B1 (enExample)
CN (2) CN105247059B (enExample)
AU (1) AU2014245779B2 (enExample)
ES (1) ES2803508T3 (enExample)
IL (2) IL241692B2 (enExample)
MX (1) MX376138B (enExample)
PH (1) PH12015502217A1 (enExample)
RU (2) RU2742607C1 (enExample)
SG (1) SG11201507928QA (enExample)
WO (1) WO2014153674A1 (enExample)
ZA (1) ZA201508327B (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11390878B2 (en) 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
CN103930435A (zh) 2011-09-30 2014-07-16 麦迪卡格公司 增加植物中病毒样颗粒的产率
US12467058B2 (en) 2013-03-28 2025-11-11 Aramis Biotechnologies Inc. Influenza virus-like particle production in plants
WO2014153674A1 (en) * 2013-03-28 2014-10-02 Medicago Inc. Influenza virus-like particle production in plants
DK3092309T3 (da) 2014-01-10 2021-04-12 Medicago Inc Cpmv-forstærkerelementer
US10563213B2 (en) 2014-03-27 2020-02-18 Medicago Inc. Modified CPMV enhancer elements
PT3981437T (pt) 2014-04-23 2025-01-15 Modernatx Inc Vacinas de ácidos nucleicos
FR3054547B1 (fr) 2016-07-29 2020-06-05 Angany Inc. Particules pseudo-virales et leurs utilisations
GB201614485D0 (en) 2016-08-25 2016-10-12 Univ Oxford Innovation Ltd Immunogenic composition
CN106822887A (zh) * 2017-01-26 2017-06-13 中国科学院微生物研究所 一种流感病毒四价亚单位疫苗及其应用
RU2020132255A (ru) 2018-03-14 2022-04-15 Медикаго Инк. Энхансер экспрессии в растениях
CN112639100A (zh) * 2018-06-27 2021-04-09 麦迪卡格公司 流感病毒血凝素突变体
CA3133166A1 (en) * 2019-03-14 2020-09-17 Mitsubishi Tanabe Pharma Corporation Endogenous plant expression enhancer
CN113249399B (zh) * 2021-05-27 2022-08-02 长沙诺合松生物科技合伙企业(有限合伙) pAM基因及其植物表达载体和应用
AU2022425707A1 (en) * 2021-12-31 2024-07-04 Mynvax Private Limited Polypeptide fragments, immunogenic composition against influenza virus, and implementations thereof
WO2025102071A1 (en) * 2023-11-09 2025-05-15 The General Hospital Corporation Hemagglutinin polypeptides and uses thereof

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5232833A (en) 1988-09-14 1993-08-03 Stressgen Biotechnologies Corporation Accumulation of heat shock proteins for evaluating biological damage due to chronic exposure of an organism to sublethal levels of pollutants
WO2000020557A2 (en) 1998-10-07 2000-04-13 Boyce Institute For Plant Research At Cornell University Gemini virus vectors for gene expression in plants
US20020169306A1 (en) * 1999-05-18 2002-11-14 Kaio Kitazato Envelope gene-deficient paramyxovirus vector
CA2406668C (en) 1999-12-06 2015-11-24 Board Of Trustees Of The University Of Illinois High affinity tcr proteins and methods
DE10109354A1 (de) 2001-02-27 2002-09-05 Icon Genetics Ag Rekombinante virale Schaltersysteme
US20030180756A1 (en) * 2002-03-21 2003-09-25 Yang Shi Compositions and methods for suppressing eukaryotic gene expression
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US7132291B2 (en) 2003-05-05 2006-11-07 Dow Agro Sciences Llc Vectors and cells for preparing immunoprotective compositions derived from transgenic plants
AU2004235800B2 (en) * 2003-05-05 2010-02-18 Dow Agrosciences Llc Stable immunoprophylactic and therapeutic compositions derived from transgenic plant cells and methods for production
US8080255B2 (en) 2003-07-11 2011-12-20 Novavax Inc. Functional influenza virus like particles (VLPs)
ES2381200T3 (es) 2005-04-29 2012-05-24 University Of Cape Town Expresión de proteínas virales en las plantas
CN103865892B (zh) * 2005-10-18 2017-04-12 诺瓦瓦克斯股份有限公司 功能性流感病毒样颗粒(vlp)
WO2007100584A2 (en) 2006-02-16 2007-09-07 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Antiviral agents and vaccines against influenza
EP1991264B1 (en) * 2006-03-07 2015-01-07 Vaxinnate Corporation Compositions that include hemagglutinin, methods of making and methods of use thereof
US7618815B2 (en) 2006-03-08 2009-11-17 University Of Kentucky Research Foundation Viral vectors useful in soybean and methods of use
WO2007135480A1 (en) 2006-05-22 2007-11-29 Plant Bioscience Limited Bipartite system, method and composition for the constitutive and inducible expression of high levels of foreign proteins in plants
AU2007286161B2 (en) 2006-08-09 2013-05-02 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
US8697088B2 (en) 2007-05-25 2014-04-15 Novavax, Inc. VLPs derived from cells that do not express a viral matrix or core protein
MX2009013665A (es) 2007-06-15 2010-06-02 Medicago Inc Produccion modificada de glicoproteinas en plantas.
CA2615372A1 (en) * 2007-07-13 2009-01-13 Marc-Andre D'aoust Influenza virus-like particles (vlps) comprising hemagglutinin
ES2554703T3 (es) * 2007-11-27 2015-12-22 Medicago Inc. Partículas recombinantes semejantes al virus de la influenza (VLP) producidas en plantas transgénicas que expresan hemaglutinina
GB0800272D0 (en) 2008-01-08 2008-02-13 Plant Bioscience Ltd Protein expression systems
SG187500A1 (en) * 2008-01-21 2013-02-28 Medicago Inc Recombinant influenza virus-like particles (vlps) produced in transgenic plants expressing hemagglutinin
CN105753948A (zh) 2008-07-08 2016-07-13 麦迪卡格公司 可溶性重组流感抗原
CA2730668C (en) 2008-07-18 2020-04-28 Medicago Inc. New influenza virus immunizing epitope
CA2736796A1 (en) 2008-08-27 2010-03-04 Arizona Board Of Regents For And On Behalf Of Arizona State University A dna replicon system for high-level rapid production of vaccines and monoclonal antibody therapeutics in plants
EP3009145A1 (en) * 2009-03-30 2016-04-20 Mount Sinai School of Medicine of New York University Influenza virus vaccines and uses thereof
EP2445928B1 (en) * 2009-06-24 2018-03-28 Medicago Inc. Chimeric influenza virus-like particles comprising hemagglutinin
FR2947875B1 (fr) 2009-07-10 2011-07-08 Raymond A & Cie Dispositif de fixation a elements de fixation multiples dont l'un est flottant
WO2011011390A1 (en) 2009-07-20 2011-01-27 Novavax, Inc. Purified recombinant influenza virus ha proteins
US20120185969A1 (en) 2009-09-04 2012-07-19 Syngenta Participations Ag Stacking of translational enhancer elements to increase polypeptide expression in plants
MX2012003372A (es) * 2009-09-22 2012-05-29 Medicago Inc Metodo para preparar proteina derivada de vegetales.
WO2011102900A1 (en) 2010-02-18 2011-08-25 Technovax, Inc. Universal virus-like particle (vlp) influenza vaccines
SG189236A1 (en) * 2010-10-04 2013-05-31 Massachusetts Inst Technology Hemagglutinin polypeptides, and reagents and methods relating thereto
CA2815887C (en) 2010-11-04 2013-12-10 Medicago Inc. Plant expression system
TWI526539B (zh) 2010-12-22 2016-03-21 苜蓿股份有限公司 植物中生產類病毒顆粒(vlp)的方法及以該方法生產之vlp
TWI620816B (zh) 2011-03-23 2018-04-11 苜蓿股份有限公司 植物衍生蛋白回收方法
BR112013032033A2 (pt) 2011-06-13 2017-05-30 Medicago Inc produção de partícula simular ao vírus da raiva em plantas
PL220281B1 (pl) * 2011-09-23 2015-09-30 Inst Biochemii I Biofizyki Polskiej Akademii Nauk Szczepionka DNA, sposób indukowania odpowiedzi immunologicznej, przeciwciała specyficznie rozpoznające białko hemaglutyniny H5 wirusa grypy i zastosowanie szczepionki DNA
CN103930435A (zh) * 2011-09-30 2014-07-16 麦迪卡格公司 增加植物中病毒样颗粒的产率
US11390878B2 (en) * 2011-09-30 2022-07-19 Medicago Inc. Increasing protein yield in plants
JP6390846B2 (ja) 2011-11-11 2018-09-19 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム ニコチアナタバカムにおいて生成される血球凝集素を含むインフルエンザウイルス様粒子（ｖｌｐ）
EP2876161B1 (en) * 2012-07-23 2018-12-05 The Institute of Biological Resources Vaccine
WO2014153674A1 (en) * 2013-03-28 2014-10-02 Medicago Inc. Influenza virus-like particle production in plants

Similar Documents

Publication Publication Date Title
JP2019141061A5 (enExample)
JP2016516415A5 (enExample)
EP1358319B1 (en) Live influenza vaccine and method of manufacture
JP5686741B2 (ja) インフルエンザワクチンの生成
RU2011105073A (ru) Вирусоподобные частицы (впч) вируса гриппа, содержащие гемагглютинин
RU2015146097A (ru) Получение вирусоподобных частиц вируса гриппа в растениях
JP6336915B2 (ja) 計算で最適化した広い反応性を示すｈ３ｎ２、ｈ２ｎ２、およびｂ型インフルエンザウイルスの抗原
CN104395336B (zh) 以计算方式优化的h5n1和h1n1流感病毒的广泛反应性抗原
JP2022172369A (ja) 卵における複製のための安定化されたｈａを有する組換えインフルエンザウイルス
RU2014116371A (ru) Повышение выхода вирусоподобных частиц в растениях
CN1202905A (zh) 副流感病毒糖蛋白和疫苗
Wang et al. Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris
JP2015506705A5 (enExample)
JP5675789B2 (ja) 免疫接種のための発現ベクターとしての水疱性口内炎ウイルスの異なる複数の抗原型
JP2005245302A (ja) 組換えインフルエンザウイルスおよびそれを用いたワクチン
Ren et al. Inclusion of membrane-anchored LTB or flagellin protein in H5N1 virus-like particles enhances protective responses following intramuscular and oral immunization of mice
JP2019506168A5 (enExample)
JP2023539713A (ja) ワクチン組成物、それらの方法、および使用
Zhao et al. Adjuvant-free, self− assembling ferritin nanoparticle vaccine coupled with influenza virus hemagglutinin protein carrying M1 and PADRE epitopes elicits cross-protective immune responses
CN103316357B (zh) 携带rsv基因的重组流感病毒嵌合疫苗及其制备方法
JP2017509657A (ja) 多量体マルチエピトープインフルエンザポリペプチドの組成物及びそれらの生成
CN1245217C (zh) 一种包含dna疫苗和灭活狂犬病毒的疫苗制剂
WO2024186901A3 (en) Broadly reactive immunogens of influenza h3 virus, compositions and methods of use thereof
JP2005170945A (ja) インフルエンザ血球凝集素多価ワクチンの製造方法
Li et al. Development of universal influenza vaccines: strategies for broadly cross-reactive influenza vaccine responses